News: Latest News

Read the latest news and select stories on Code Bio’s work below. 
December 2, 2021

Code Biotherapeutics Appoints Erin Brubaker as Chief Operating Officer

Code Biotherapeutics, Inc., a biotechnology company pioneering targeted non-viral delivery of genetic medicines, announces the appointment of Erin Brubaker as Chief Operating Officer, effective immediately.

April 20, 2021

Code Biotherapeutics Launches with $10 Million in Seed Financing to Develop Therapies for Debilitating Genetic Diseases

Code Biotherapeutics, Inc., a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies for rare and prevalent genetic diseases, launches today with $10 million in financing and headquarters in the Philadelphia region’s leading gene therapy epicenter.

April 16, 2021

Code Biotherapeutics Appoints Lauren M. Kaskiel, MBA as Chief Business Officer

Code Biotherapeutics, Inc., a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies for rare and genetic diseases, announces today that Lauren M. Kaskiel, MBA will join the company as its Chief Business Officer.